T-cell surface glycoprotein CD3 delta chain (CD3D) (CD3D)

The T-cell surface glycoprotein CD3 delta chain (CD3D) is a vital component of the T-cell receptor (TCR) complex, playing a critical role in the adaptive immune system [1, 2]. It forms a heterodimer with the CD3 epsilon chain, which, along with other CD3 subunits, couples antigen recognition by the TCR to intracellular signaling pathways [3]. The cytoplasmic domain of CD3 delta contains a conserved immunoreceptor tyrosine-based activation motif (ITAM) that is essential for signal transduction upon TCR engagement [1]. Phosphorylation of this ITAM by Src-family kinases initiates a cascade leading to T-cell activation, proliferation, and cytokine production [3]. Mutations in the CD3D gene are associated with severe combined immunodeficiency (SCID), highlighting its necessity for normal T-cell development [4]. In therapeutic contexts, the CD3 complex is a primary target for bispecific antibodies and monoclonal antibodies designed to either deplete T-cells in autoimmune conditions or redirect them to eliminate cancer cells [5]. While most clinical antibodies bind the extracellular portion of the CD3 epsilon subunit, the signaling integrity of the CD3 delta cytoplasmic domain is fundamental to the efficacy of these interventions [1, 5].

Other names

CD3 deltaT3DCD3-DELTAT-cell receptor T3 delta chainCD3 delta cytoplasmic domain

T-cell activation via TCR complex engagement, T-cell redirection to tumor cells, or T-cell modulation/depletion